Literature DB >> 12783730

[Circadian variations in proinflammatory cytokine concentrations in acute myocardial infarction].

Alberto Domínguez Rodríguez1, Pedro Abreu González, Martín J García, Alejandro de la Rosa, Manuel Vargas, Francisco Marrero.   

Abstract

INTRODUCTION AND
OBJECTIVES: The concentration of certain proinflammatory cytokines has been found to be elevated in patients with acute coronary syndrome. Many studies have shown that coronary ischemic accidents do not show a uniform distribution throughout the day, but instead exhibit rhythmic variations. The objective of this study is to determine whether there is a circadian pattern of variation in the concentrations of proinflammatory cytokines in patients with acute myocardial infarction. PATIENTS AND
METHOD: The sample included 40 patients with acute myocardial infarction and 40 controls. Levels of interleukin 6 and 1 beta were determined in the first 24 hours after the acute coronary ischemic episode. Blood samples were extracted at 3:00 a.m. (period of darkness) and at 10:00 a.m. (period of daylight).
RESULTS: Both groups were similar in age, sex distribution, and coronary risk factors. Interleukin 6 levels showed a significant variation between daylight and nighttime concentrations in patients with acute myocardial infarction and controls (41.93 5.90/100.39 13.60 vs 25.76 4.45/52.67 7.73 pg/ml). However, interleukin 6 concentrations were higher in the acute myocardial infarction group than in the control group. Interleukin 1 beta concentrations did not vary between daylight and darkness.
CONCLUSIONS: In both the control group and acute myocardial infarction group, interleukin 6 concentrations varied between daylight and darkness. Patients with acute myocardial infarction shown a higher concentration of interleukin 6 secondary to the physiological response to tissue damage. Circadian variations can affect the measurements obtained for different physiological and biochemical parameters.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12783730     DOI: 10.1016/s0300-8932(03)76916-4

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  6 in total

Review 1.  Pharmacokinetic and pharmacodynamic considerations in the development of therapeutic proteins.

Authors:  Iftekhar Mahmood; Martin D Green
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 2.  Neuroinflammation and psychiatric illness.

Authors:  Souhel Najjar; Daniel M Pearlman; Kenneth Alper; Amanda Najjar; Orrin Devinsky
Journal:  J Neuroinflammation       Date:  2013-04-01       Impact factor: 8.322

3.  Diurnal Variation of Circulating Interleukin-6 in Humans: A Meta-Analysis.

Authors:  Gustav Nilsonne; Mats Lekander; Torbjörn Åkerstedt; John Axelsson; Michael Ingre
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

Review 4.  The treatment strategies of autoimmune disease may need a different approach from conventional protocol: a review.

Authors:  S Chandrashekara
Journal:  Indian J Pharmacol       Date:  2012 Nov-Dec       Impact factor: 1.200

5.  Diagnostic dilemma of IgG4-related primary localized cervical lymphadenopathy associated with aberrant IL-6 expression level.

Authors:  Moriyoshi Nakamura; Osamu Iwamoto; Takahiro Chino; Keita Todoroki; Jingo Kusukawa
Journal:  Diagn Pathol       Date:  2016-05-03       Impact factor: 2.644

6.  The effects of diurnal intermittent fasting on proinflammatory cytokine levels while controlling for sleep/wake pattern, meal composition and energy expenditure.

Authors:  Aljohara S Almeneessier; Abdulrahman A BaHammam; Mohammed Alzoghaibi; Awad H Olaish; Samar Z Nashwan; Ahmed S BaHammam
Journal:  PLoS One       Date:  2019-12-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.